Rein Therapeutics Inc (RNTX) — Defensive Interval Ratio
Rein Therapeutics Inc (RNTX) has a Defensive Interval Ratio of 0 days as of December 2023. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $12.01K/day. See Rein Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Rein Therapeutics Inc Defensive Interval Ratio (2017–2023)
This chart shows how Rein Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2017 to 2023. As of December 2023, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. See RNTX net asset quality score to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Rein Therapeutics Inc (2017–2023)
The table below presents the year-by-year Defensive Interval Ratio for Rein Therapeutics Inc from 2017 to 2023, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Rein Therapeutics Inc market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 0 days | $0.00 | $12.01K/day | $- | $0.00 | ▼ -1731 days |
| 2022 | 1731 days | $16.05 Million | $9.27K/day | $- | $16.05 Million | ▼ -1697 days |
| 2021 | 3428 days | $42.33 Million | $12.35K/day | $- | $42.33 Million | ▲ +2805 days |
| 2020 | 623 days | $6.76 Million | $10.85K/day | $- | $6.76 Million | ▼ -188 days |
| 2019 | 811 days | $12.97 Million | $16.00K/day | $- | $12.97 Million | ▲ +127 days |
| 2018 | 684 days | $10.06 Million | $14.71K/day | $- | $10.06 Million | ▼ -2218 days |
| 2017 | 2902 days | $38.89 Million | $13.40K/day | $- | $38.89 Million | — |